Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Receptors, Lysophospholipid
Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins.
Evaluation of a measure of end-stage knee osteoarthritis compared to total knee replacement: An observational study using multicohort data.
YAP/TAZ-mediated regulation of laminin 332 is enabled by ?4 integrin repression of ZEB1 to promote ferroptosis resistance.
Management of dyspnea at the end of life: relief for patients and surgeons.
See All 8 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Management of dyspnea at the end of life: relief for patients and surgeons.
Mosenthal AC, Lee KF. Management of dyspnea at the end of life: relief for patients and surgeons. J Am Coll Surg. 2002 Mar; 194(3):377-86.
View in:
PubMed
subject areas
Advance Directives
Aged
Anti-Anxiety Agents
Benzodiazepines
Dyspnea
Humans
Male
Narcotics
Oxygen Inhalation Therapy
Palliative Care
Respiration, Artificial
Terminal Care
Ventilator Weaning
authors with profiles
Anne C Mosenthal MD, FACS, MAMSE